SCHEMBL24279031

SCHEMBL24279031

c1ccc(-c2nc(-c3ccccc3)c3oc4cc(-n5c6ccccc6c6c7oc8ccccc8c7ccc65)ccc4c3n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.41
MAPT P10636 12/20 0.40
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 3/20 0.39
POLB P06746 3/20 0.39
HPGD P15428 2/20 0.39
LMNA P02545 5/20 0.39
HSD17B10 Q99714 3/20 0.39
MAPK1 P28482 2/20 0.39
NPSR1 Q6W5P4 4/20 0.39
KMT2A Q03164 7/20 0.39
MEN1 O00255 6/20 0.39
USP2 O75604 1/20 0.38
HTT P42858 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
GAA P10253 2/20 0.37
ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19248039 0.94 TSHR (0.43) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL19247117 0.94 TSHR (0.43) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL19247098 0.92 TSHR (0.39) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL19248049 0.92 TSHR (0.41) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL24279032 0.91 ALDH1A1 (0.41) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL24278999 0.91 TSHR (0.39) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL26415902 0.89 TSHR (0.37) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL21740464 0.88 TSHR (0.35) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL24279029 0.88 TSHR (0.41) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL22141852 0.87 WHR1 (0.37) TSHRMAPTALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220115600-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220115600-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, AOX1, CYP2E1 TSHR 3403/4885MAPT 2791/4885ALDH1A1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.